Search results

Discover four key topics to expect to cover during your first meeting with a contract research organization, to set yourself up for a long-lasting partnership.

Discover FDA guidances for oligonucleotide bioanalysis, safety assessments, and clinical pharmacology, and how Altasciences supports regulatory-compliant drug development.

In Issue 7 of The Altascientist, we discuss how age, biological sex, genetics, and drug-drug interactions can affect drug metabolism and outcomes.

Discover how Altasciences reduced clinical trial start-up timelines by 70%, initiating the first dose of a Phase I MAD study in just 3.5 weeks.

Explore Canada `s advantages for early-phase clinical trials: streamlined regulatory pathways, diverse participant pool, and cost-effectiveness.

Explore the process required for manufacturing a highly potent API for an ophthalmic indication, based on a case study involving loteprednol etabonate, a topical corticosteroid used to treat eye inflammations.